About this Journal Submit a Manuscript Table of Contents
Journal of Nanomaterials
Volume 2013 (2013), Article ID 843647, 9 pages
http://dx.doi.org/10.1155/2013/843647
Research Article

Antimicrobial Activity of Hippurate Nanocomposite and Its Cytotoxicity Effect in Combination with Cytarabine against HL-60

1Laboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
2Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
3Materials Synhesis and Characterization Laboratory (MSCL), Institute of Advanced Technology, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
4Department of Nutrition and Dietetics, Faculty of Medicine and Health Science, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia

Received 27 August 2012; Revised 27 November 2012; Accepted 28 November 2012

Academic Editor: Xiliang Luo

Copyright © 2013 Samer Hasan Hussein Al Ali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Rives, Layered Double Hydroxides: Present and Future, Nova Science, New York, NY, USA, 2001.
  2. G. G. C. Arizaga, K. G. Satyanarayana, and F. Wypych, “Layered hydroxide salts: synthesis, properties and potential applications,” Solid State Ionics, vol. 178, no. 15–18, pp. 1143–1162, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Ladewig, P. X. Zhi, and Q. L. Gao, “Layered double hydroxide nanoparticles in gene and drug delivery,” Expert Opinion on Drug Delivery, vol. 6, no. 9, pp. 907–922, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Aisawa, “Nucleotide transport efficiency to leukemia cells by layered double hydroxide,” Kagaku to Kogyo, vol. 55, no. 7, p. 809, 2002.
  5. J. H. Choy, M. Park, and J. M. Oh, “Bio-nanohybrids based on layered double hydroxide,” Current Nanoscience, vol. 2, no. 3, pp. 275–281, 2006. View at Scopus
  6. J. H. Choy, “Biological hybrid materials for drug delivery system,” Solid State Phenomena, vol. 111, pp. 1–6, 2006.
  7. J. H. Choy and M. Park, “Nanohybridization of biomolecules with layered double hydroxides and hydroxy double salts for advanced applications,” Clay Science, vol. 12, pp. 52–56, 2005.
  8. M. Louer, D. Louer, and D. Grandjean, “Etude structurale des hydroxynitrates de nickel et de zinc. I. Classification structurale,” Acta Crystallographica B, vol. 29, pp. 1696–1703, 1973.
  9. S. H. H. Al Ali, M. Al-Qubaisi, M. Z. Hussein, Z. Zainal, and M. N. Hakim, “Preparation of hippurate-zinc layered hydroxide nanohybrid and its synergistic effect with tamoxifen on HepG2 cell lines,” International Journal of Nanomedicine, vol. 6, pp. 3099–3111, 2011.
  10. S. H. Al Ali, M. Al-Qubaisi, M. Z. Hussein, M. Ismail, Z. Zainal, and M. N. Hakim, “Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells,” International Journal of Nanomedicine, vol. 7, pp. 3351–3363, 2012.
  11. M. Z. Hussein, S. H. Al Ali, Z. Zainal, and M. N. Hakim, “Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent,” International Journal of Nanomedicine, vol. 6, pp. 1373–1383, 2011.
  12. J. M. Andrews, “BSAC standardized disc susceptibility testing method,” Journal of Antimicrobial Chemotherapy, vol. 48, no. 1, pp. 43–57, 2001. View at Scopus
  13. M. Yin, Y. Gu, I. L. Kuskovsky et al., “Zinc oxide quantum rods,” Journal of the American Chemical Society, vol. 126, no. 20, pp. 6206–6207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. P. Newman and W. Jones, “Comparative study of some layered hydroxide salts containing exchangeable interlayer anions,” Journal of Solid State Chemistry, vol. 148, no. 1, pp. 26–40, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Leclerc and R. L. Momparler, “Effect of the interval between exposures to cytarabine on its cytotoxic action on HL-60 myeloid leukemic cells,” Cancer Treatment Reports, vol. 68, no. 9, pp. 1143–1148, 1984. View at Scopus
  16. D. Y. Bouffard and R. L. Momparler, “Comparison of the induction of apoptosis in human leukemic cell lines by 2', 2'-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside,” Leukemia Research, vol. 19, no. 11, pp. 849–856, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. Choy, J. S. Jung, J. M. Oh et al., “Layered double hydroxide as an efficient drug reservoir for folate derivatives,” Biomaterials, vol. 25, no. 15, pp. 3059–3064, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. T. Hamilton-Miller and W. Brumfitt, “Methenamine and its salts as urinary tract antiseptics. Variables affecting the antibacterial activity of formaldehyde, mandelic acid, and hippuric acid in vitro,” Investigative Urology, vol. 14, no. 4, pp. 287–291, 1977. View at Scopus
  19. D. Kaye, “Antibacterial activity of human urine,” Journal of Clinical Investigation, vol. 47, no. 10, pp. 2374–2390, 1968. View at Scopus
  20. Y. L. Lee, J. Owens, L. Thrupp, and T. C. Cesario, “Does cranberry juice have antibacterial activity?” Journal of the American Medical Association, vol. 283, no. 13, p. 1691, 2000. View at Scopus
  21. I. Ofek, J. Goldhar, D. Zafriri, H. Lis, R. Adar, and N. Sharon, “Anti-Escherichia coli adhesin activity of cranberry and blueberry juices,” The New England Journal of Medicine, vol. 324, no. 22, p. 1599, 1991. View at Scopus
  22. R. Raz, B. Chazan, and M. Dan, “Cranberry juice and urinary tract infection,” Clinical Infectious Diseases, vol. 38, no. 10, pp. 1413–1419, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Mesaros, P. Nordmann, P. Plésiat et al., “Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium,” Clinical Microbiology and Infection, vol. 13, no. 6, pp. 560–578, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. A. R. Naylor, P. D. Hayes, and S. Darke, “A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA,” European Journal of Vascular and Endovascular Surgery, vol. 21, no. 4, pp. 289–294, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. J. N. Sharpe, E. H. Shively, and H. C. Polk, “Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus,” American Journal of Surgery, vol. 189, no. 4, pp. 425–428, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. D. M. Livermore, “Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?” Clinical Infectious Diseases, vol. 34, no. 5, pp. 634–640, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Huh and Y. J. Kwon, “‘Nanoantibiotics’: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era,” Journal of Controlled Release, vol. 156, pp. 128–145, 2011.
  28. S. Parveen, R. Misra, and S. K. Sahoo, “Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging,” Nanomedicine, vol. 8, no. 2, pp. 147–166, 2012.